Skip to content

To compare pain relieving effect of two drugs used in block in patients undergoing breast surgery.

To evaluate and compare analgesic efficacy of dexmedetomidine as adjuvant to ropivacaine with ropivacaine alone under ultrasound guided serratus anterior plane block,in patient for breast surgery: A randomised controlled comparative single blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039836
Enrollment
50
Registered
2022-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Serratus anterior plane block in patients undergoing breast surgery with Ropivacaine and Dexmedetomidine: Serratus anterior plane block will be given in patients undergoing breast surge

Sponsors

Dr Vikram Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiology (ASA) physical status 1 and 2,Patient between age group of 18-65. Patient who are posted for breast surgery

Exclusion criteria

Exclusion criteria: 1.Patientâ??s refusal for block 2.Patients with known allergic reactions to local anaesthetics 3.Patients with history of coagulopathy 4.Patients with infection at the block site 5.Pregnancy 6.Bradycardia and heart block

Design outcomes

Primary

MeasureTime frame
To study the pain free durationTimepoint: At 0,30,60 minute, 1,2,3,4,5,6,8,12,24 hour after shifting to post anaesthesia care unit

Secondary

MeasureTime frame
1.Analgesic requirement in first 24 hour 2.Patient satisfaction using Likert scaleTimepoint: first 24 hour;Any side EffectTimepoint: first 24 hour

Countries

India

Contacts

Public Contactdr Aparna Sharma

Indira Gandhi Medical College, Shimla

aparnasharmaraina@gmail.com9418083224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026